# Evidence-based Therapist Guided Introduction to Online Heavy Cannabis Use Treatment in Canadian Adults: A Randomized Controlled Trial (RCT) > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/therapist-guided-cannabis-treatment-online-heavy-use-trial/ > **Published:** 2026-04-27T08:01:56-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:02:54-04:00 > **Clinical Summary:** Explore therapist guided cannabis treatment in an online program for heavy cannabis use in Canadian adults with evidence from a randomized controlled trial. --- CED Clinical Relevance  #86High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic Journal Journal of [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) Study Type Randomized Trial Population Human participants Why This Matters This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and clinical practice. Clinicians monitoring evidence in this area should review the source material. Clinical Summary Many people who engage in heavy cannabis use do not seek treatment, and those who do are often met with long treatment wait times or high cost of services. Online treatment programs reduce barriers to accessing treatment in a timely manner. Online cannabis use treatment programs are effective, showing moderate effect sizes, particularly with text-based therapist support. Literature suggests brief therapist-guided introductions (i.e., self-completed interventions offered with the support of a therapist) informed by Motivational Enhancement Therapy (MET) may help to bolster and maintain program gains. The current evaluation of MET-informed therapist-guided introduction was conducted with a sample of Canadians who report heavy cannabis use, using a new Canadian version of CANreduce, an online treatment program for heavy cannabis use. The intervention was pre-registered on clinicaltrials.gov for traceability (ID: NCT04965012). Participants (N = 152) were randomized into one of three condit Dr. Caplan’s Take “This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.” Clinical Perspective 🧠 Clinicians should review this item in the context of their current practice and patient population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Evidence-based%20therapist%20guided%20introduction%20to%20online%20heavy%20cannabis%20use%20treatment%20in%20Canadian%20adul...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fevidence-based-therapist-guided-introduction-to-online-heavy-cannabis-use-t%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fevidence-based-therapist-guided-introduction-to-online-heavy-cannabis-use-t%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Evidence-based%20therapist%20guided%20introduction%20to%20online%20heavy%20cannabis%20use%20treatment%20in%20Canadian%20adul...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fevidence-based-therapist-guided-introduction-to-online-heavy-cannabis-use-t%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41547862/](https://pubmed.ncbi.nlm.nih.gov/41547862/) Table of Contents - [FAQ](#FAQ)[Why are online programs being studied for heavy cannabis use?](#Why_are_online_programs_being_studied_for_heavy_cannabis_use) - [Do online treatment programs for cannabis use actually work?](#Do_online_treatment_programs_for_cannabis_use_actually_work) - [What is a therapist-guided introduction to an online cannabis program?](#What_is_a_therapist-guided_introduction_to_an_online_cannabis_program) - [What is CANreduce, and how was this trial set up?](#What_is_CANreduce_and_how_was_this_trial_set_up) - [Related](#Related) ## FAQ ### Why are online programs being studied for heavy cannabis use? Many people who use cannabis heavily do not seek treatment, and those who do often face long wait times or high costs. Online treatment programs reduce these barriers and allow people to access treatment in a timely manner. This trial evaluated an online program for Canadian adults who report heavy cannabis use. ### Do online treatment programs for cannabis use actually work? According to the summary, online cannabis use treatment programs are effective, showing moderate effect sizes, particularly when they include text-based therapist support. This statement reflects the existing literature that motivated the trial, rather than the results of this specific trial. ### What is a therapist-guided introduction to an online cannabis program? It is a brief, self-completed intervention offered with the support of a therapist. In this trial, the introduction was informed by Motivational Enhancement Therapy. Previous literature suggests this kind of therapist-guided introduction may help bolster and maintain the gains people make in an online program. ### What is CANreduce, and how was this trial set up? CANreduce is an online treatment program for heavy cannabis use. This trial used a new Canadian version of it with Canadians who report heavy cannabis use, randomizing 152 participants into one of three conditions. The intervention was pre-registered on clinicaltrials.gov for traceability under the ID NCT04965012. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [[Academic] Seeking Participants for Study on Cannabis + Sexual Health (18+, female, cannabis user)](https://cedclinic.com/cannabis-sexual-health-study-female-participants/) Join an academic study exploring cannabis use and [sexual health](https://cedclinic.com/adolescent-cannabis-use-sexual-behavior-study/) in adult female cannabis users. Contribute to advancing [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). [Learn More](https://cedclinic.com/cannabis-sexual-health-study-female-participants/) [New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) Discover emerging evidence on how cannabinoids such as CBD and CBG could support [liver health](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) and disease management. [Read Research](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) [Medical Cannabis Significantly Reduced Use of Opioids and Other Rx Drugs](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) Explore findings on how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) may reduce reliance on opioids and prescription medications in clinical settings. [Explore Findings](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).